202 related articles for article (PubMed ID: 20454507)
1. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract][Full Text] [Related]
2. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
3. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.
Xue J; Zhu W; Song J; Jiao Y; Luo J; Yu C; Zhou J; Wu J; Chen M; Ding WQ; Cao J; Zhang S
Oncogene; 2018 Feb; 37(7):953-962. PubMed ID: 29059162
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
Shimasaki T; Ishigaki Y; Nakamura Y; Takata T; Nakaya N; Nakajima H; Sato I; Zhao X; Kitano A; Kawakami K; Tanaka T; Takegami T; Tomosugi N; Minamoto T; Motoo Y
J Gastroenterol; 2012 Mar; 47(3):321-33. PubMed ID: 22041920
[TBL] [Abstract][Full Text] [Related]
5. Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.
Kitano A; Shimasaki T; Chikano Y; Nakada M; Hirose M; Higashi T; Ishigaki Y; Endo Y; Takino T; Sato H; Sai Y; Miyamoto K; Motoo Y; Kawakami K; Minamoto T
PLoS One; 2013; 8(2):e55289. PubMed ID: 23408967
[TBL] [Abstract][Full Text] [Related]
6. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein kinase Cbeta by enzastaurin enhances radiation cytotoxicity in pancreatic cancer.
Spalding AC; Watson R; Davis ME; Kim AC; Lawrence TS; Ben-Josef E
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6827-33. PubMed ID: 18006785
[TBL] [Abstract][Full Text] [Related]
8. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
Zeng J; Liu D; Qiu Z; Huang Y; Chen B; Wang L; Xu H; Huang N; Liu L; Li W
PLoS One; 2014; 9(3):e91231. PubMed ID: 24618715
[TBL] [Abstract][Full Text] [Related]
9. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
[TBL] [Abstract][Full Text] [Related]
10. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
11. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
[TBL] [Abstract][Full Text] [Related]
12. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
Yang HW; Liu GH; Liu YQ; Zhao HC; Yang Z; Zhao CL; Zhang XF; Ye H
Biomed Pharmacother; 2016 Oct; 83():593-601. PubMed ID: 27459115
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.
Nakayama M; Hisatsune J; Yamasaki E; Isomoto H; Kurazono H; Hatakeyama M; Azuma T; Yamaoka Y; Yahiro K; Moss J; Hirayama T
J Biol Chem; 2009 Jan; 284(3):1612-9. PubMed ID: 18996844
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway.
Gong F; Wang G; Ye J; Li T; Bai H; Wang W
Oncol Rep; 2013 Dec; 30(6):2976-82. PubMed ID: 24065186
[TBL] [Abstract][Full Text] [Related]
16. Wnt/Glycogen Synthase Kinase 3β/β-catenin Signaling Activation Mediated Sevoflurane Preconditioning-induced Cardioprotection.
Liu JD; Deng Q; Tian HH; Pang YT; Deng GL
Chin Med J (Engl); 2015 Sep; 128(17):2346-53. PubMed ID: 26315083
[TBL] [Abstract][Full Text] [Related]
17. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.
Li M; Zhou W; Yuan R; Chen L; Liu T; Huang D; Hao L; Xie Y; Shao J
FEBS Lett; 2015 Apr; 589(9):1018-25. PubMed ID: 25771860
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3β promotes osteogenic differentiation of murine adipose-derived stromal cells.
Huh JE; Ko R; Jung HJ; Lee SY
PLoS One; 2013; 8(1):e54551. PubMed ID: 23342170
[TBL] [Abstract][Full Text] [Related]
19. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
20. Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway.
Yan X; Lyu T; Jia N; Yu Y; Hua K; Feng W
PLoS One; 2013; 8(5):e63731. PubMed ID: 23667667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
